
Search News
-
Published on Apr 26, 2025Source: Endpoints News - Neutral
-
Published on Apr 26, 2025
Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in ...
Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than half of responders remaining cancer-free at one year after CR Results reinforce potential of TAR-200 to transform outcomes for certain types of …
Source: WFMZ - Pennsylvania - Neutral -
Published on Apr 26, 2025
UGN-301 Shows Early Tolerability in Recurrent Non–Muscle-Invasive Bladder Cancer
UGN-301, an intravesical formulation of zalifrelimab, proved to be well tolerated with an acceptable toxicity profile at all dose levels evaluated in patients with recurrent non–muscle-invasive bladder cancer (NMIBC) enrolled in a phase 1 study ( …
Source: OncLive - Pending -
Published on 01:42 GMT
AUA 2025: Bladder EpiCheck-triggered Photodynamic Diagnosis Biopsies Detect High Grade Recurrences Missed by White Light ...
(UroToday.com) The American Urological Association (AUA) 2025 Annual Meeting, held in Las Vegas, NV, was host to a bladder cancer epidemiology and evaluation moderated poster session. Dr. Paramananthan Mariappan presented a study evaluating Bladder …
Source: UroToday - Neutral -
Published on 01:16 GMT
Painful sex. Shrinking bits. White patches, veins and the signs of cancer: DR PHILLIPA KAY's guide to EVERYTHING that ...
More often than not, euphemisms are used to describe female genitals. I won’t list them, but they are numerous and, let’s say, colourful. Some are babyish terms parents use when talking to children. Others are schoolyard slang that, oddly, remain in common …
Source: Daily Mail - Right-wing -
Published on Apr 25, 2025
Understanding the FDA Imfinzi Combo Approval for Bladder Cancer Care
Adjuvant treatment with Imfinzi (durvalumab) plus chemotherapy, followed by single-agent, adjuvant Imfinzi following radical cystectomy received U.S. Food and Drug Administration (FDA) approval for muscle invasive bladder cancer in March of 2025, marking a …
Source: Cure Today - Neutral -
Published on Apr 25, 2025
KD-01 armed oncolytic virus demonstrates antitumor activity in bladder cancer models
Cancer Bacillus Calmette-Guérin (BCG) remains the primary treatment for patients with high-risk bladder cancer, but resistance develops in 30% to 40% of cases. The use of oncolytic viruses has emerged as a promising alternative therapeutic strategy. …
Source: BioWorld - Pending -
Published on Apr 25, 2025
Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer ...
Patient-centric management necessitates providing care aligned with patients' values, preferences, and expressed needs. Therefore, critical assessment of bladder preservation therapies (BPTs) as alternatives to radical cystectomy (RC) for muscle- …
Source: UroToday - Neutral -
Published on Apr 26, 2025
She survived a stroke, a heart transplant and cancer. How this Cedar Crest College student persevered
Three years ago, Caroline Laubach was fighting for her life while she waited for a new heart to replace the failing one she was born with. It’s a far cry from the Laubach who will cross the finish line at Gift of Life’s Donor Dash Sunday at Philadelphia’s …
Source: Morning Call - Pennsylvania - Neutral -
Published on Apr 26, 2025
Shaan Opens Up About Prostate Cancer Scare: All You Need To Know About It
Last Updated:April 26, 2025, 10:48 IST Bollywood playback singer Shaan recently shared his experience related to a prostate cancer scare in 2020. Shaan talked about how men's health issues are seldom discussed.Bollywood playback singer Shaan recently …
Source: News18 - Center-right